May 152017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced the appointment of Garry Nicholson to its board of directors.… => Read more

Five Prime Therapeutics appoints Garry Nicholson to its Board of Directors

From:: Five Prime Therapeutics appoints Garry Nicholson to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: